These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109 [TBL] [Abstract][Full Text] [Related]
3. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767 [TBL] [Abstract][Full Text] [Related]
4. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion. Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours. Preobrazhenskaya EV; Suleymanova AM; Bizin IV; Zagrebin FA; Romanko AA; Saitova ES; Mulkidzhan RS; Imyanitov EN Histopathology; 2023 Jul; 83(1):109-115. PubMed ID: 37071060 [TBL] [Abstract][Full Text] [Related]
7. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760 [TBL] [Abstract][Full Text] [Related]
8. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. Alassiri AH; Ali RH; Shen Y; Lum A; Strahlendorf C; Deyell R; Rassekh R; Sorensen PH; Laskin J; Marra M; Yip S; Lee CH; Ng TL Am J Surg Pathol; 2016 Aug; 40(8):1051-61. PubMed ID: 27259007 [TBL] [Abstract][Full Text] [Related]
9. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma. Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751 [TBL] [Abstract][Full Text] [Related]
10. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma. Parker BM; Parker JV; Lymperopoulos A; Konda V J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295 [TBL] [Abstract][Full Text] [Related]
11. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors. Hornick JL; Sholl LM; Dal Cin P; Childress MA; Lovly CM Mod Pathol; 2015 May; 28(5):732-9. PubMed ID: 25612511 [TBL] [Abstract][Full Text] [Related]
12. Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with ETV6::NTRK3 fusion. Han Q; Zhang Z; He X; Chen M; Pang X; Chen C; Du T; Zhang H Histopathology; 2023 May; 82(6):925-936. PubMed ID: 36748182 [TBL] [Abstract][Full Text] [Related]
13. Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma. Jang JS; Wang X; Vedell PT; Wen J; Zhang J; Ellison DW; Evans JM; Johnson SH; Yang P; Sukov WR; Oliveira AM; Vasmatzis G; Sun Z; Jen J; Yi ES J Thorac Oncol; 2016 Nov; 11(11):1891-1900. PubMed ID: 27343444 [TBL] [Abstract][Full Text] [Related]
14. Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors. Kurihara T; Suehara Y; Akaike K; Hayashi T; Kohsaka S; Ueno T; Hasegawa N; Takagi T; Sasa K; Okubo T; Kim Y; Mano H; Yao T; Kaneko K; Saito T Sci Rep; 2020 Oct; 10(1):18724. PubMed ID: 33127954 [TBL] [Abstract][Full Text] [Related]
15. Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing. Yao Q; Bai Q; Zhang X; Ji G; Chang H; Cai X; Yu L; Wang J; Zhu X; Zhou X Arch Pathol Lab Med; 2022 Oct; 146(10):1234-1242. PubMed ID: 35041745 [TBL] [Abstract][Full Text] [Related]
16. Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases. Lopez-Nunez O; John I; Panasiti RN; Ranganathan S; Santoro L; Grélaud D; Wu T; Buccoliero AM; Casanova M; Alaggio R; Surrey LF Mod Pathol; 2020 Apr; 33(4):576-590. PubMed ID: 31690781 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas. Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422 [TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study. Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750 [TBL] [Abstract][Full Text] [Related]
19. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report. Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845 [TBL] [Abstract][Full Text] [Related]
20. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]